Cargando…

Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The advent of immuno-oncology (IO) agents, particularly immune checkpoint inhibitors (ICIs), has changed the treatment landscape of non-small cell lung cancer (NSCLC). We performed a retro-prospective study to describe the patients’ outcomes prior to and after the local regulatory ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danesi, Valentina, Massa, Ilaria, Foca, Flavia, Delmonte, Angelo, Crinò, Lucio, Bronte, Giuseppe, Ragonesi, Maria, Maltoni, Roberta, Manunta, Silvia, Cravero, Paola, Andrikou, Kalliopi, Priano, Ilaria, Balzi, William, Gentili, Nicola, Burke, Thomas, Altini, Mattia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497168/ https://www.ncbi.nlm.nih.gov/pubmed/36139641 http://dx.doi.org/10.3390/cancers14184481

Ejemplares similares

How to discriminate non-small cell lung cancer (NSCLC) cases from an Italian administrative database? A retrospective, secondary data use study for evaluating a novel algorithm performance
por: Balzi, William, et al.
Publicado: (2021)

The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy
por: Canale, Matteo, et al.
Publicado: (2022)

The challenge of sustainability in healthcare systems: cost of radiotherapy in the last month of life in an Italian cancer center
por: Rossi, Romina, et al.
Publicado: (2020)

High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis
por: Bronte, Giuseppe, et al.
Publicado: (2022)

Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer
por: Andrikou, Kalliopi, et al.
Publicado: (2023)

Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients
por: Ulivi, Paola, et al.
Publicado: (2022)

Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience
por: Ulivi, Paola, et al.
Publicado: (2021)

The challenge of sustainability in healthcare systems: frequency and cost of diagnostic procedures in end-of-life cancer patients
por: Massa, Ilaria, et al.
Publicado: (2018)

Assessment of Cancer Care Costs in Disease-Specific Cancer Care Pathways
por: Altini, Mattia, et al.
Publicado: (2020)

Targeting RET-rearranged non-small-cell lung cancer: future prospects
por: Bronte, Giuseppe, et al.
Publicado: (2019)

Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma
por: Gianni, Caterina, et al.
Publicado: (2021)

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
por: Maltoni, Roberta, et al.
Publicado: (2021)

Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study
por: Maltoni, Roberta, et al.
Publicado: (2022)

Chemotherapy and palliative care near end-of life: examining the appropriateness at a cancer institute for colorectal cancer patients
por: Massa, Ilaria, et al.
Publicado: (2018)

The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer
por: Verlicchi, Alberto, et al.
Publicado: (2023)

How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers?
por: Bertoni, Lucia, et al.
Publicado: (2021)

The Challenge of Sustainability of High-Cost Oncological Drugs: A Budgeting Model in an Italian Cancer Center
por: Masini, Carla, et al.
Publicado: (2021)

Obesity and Dose of Anti-cancer Therapy: Are We Sure to Be on the Right Track in the Precision Medicine Era?
por: Rossi, Tania, et al.
Publicado: (2021)

The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects
por: Bravaccini, Sara, et al.
Publicado: (2021)

Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
por: Nicolini, Fabio, et al.
Publicado: (2020)

Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting
por: Nicolini, Fabio, et al.
Publicado: (2020)

Emilia-Romagna Surgical Colorectal Cancer Audit (ESCA): a value-based healthcare retro-prospective study to measure and improve the quality of surgical care in colorectal cancer
por: Massa, Ilaria, et al.
Publicado: (2022)

Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer
por: De Matteis, Serena, et al.
Publicado: (2019)

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer
por: Bronte, Giuseppe, et al.
Publicado: (2021)

Radiology imaging management in an Italian cancer center (IRST IRCCS) during the COVID-19 pandemic
por: Rossi, Alice, et al.
Publicado: (2020)

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
por: Maltoni, Roberta, et al.
Publicado: (2020)

Radiotherapy and palliative care outpatient clinic: a new healthcare integrated model in Italy
por: Rossi, Romina, et al.
Publicado: (2023)

BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives
por: Molinaro, Eleonora, et al.
Publicado: (2020)

PCN224 An Italian Experience: How the COVID-19 Era HAS Modified the Radiological Activity in a Cancer Hospital
por: Rossi, A., et al.
Publicado: (2020)

High-dose chemotherapy in a patient with coronavirus disease (COVID-19)
por: De Giorgi, Ugo, et al.
Publicado: (2020)

Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations
por: Canale, Matteo, et al.
Publicado: (2022)

Incidence and Prevalence Analysis of Non-Small-Cell and Small-Cell Lung Cancer Using Administrative Data
por: Ricotti, Andrea, et al.
Publicado: (2021)

The prognostic effects of circulating myeloid-derived suppressor cells in non-small cell lung cancer: systematic review and meta-analysis
por: Bronte, Giuseppe, et al.
Publicado: (2022)

Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint Inhibitors
por: Bronte, Giuseppe, et al.
Publicado: (2021)

KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population
por: Fancelli, Sara, et al.
Publicado: (2022)

Scrambler therapy: what's new after 15 years? The results from 219 patients treated for chronic pain
por: Ricci, Marianna, et al.
Publicado: (2019)

Second Generation Needling Techniques for the Treatment of Chondral Defects in Animal Model
por: Zedde, Pietro, et al.
Publicado: (2017)

Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold
por: Maltoni, Roberta, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach?
por: Bronte, Giuseppe, et al.
Publicado: (2023)

Surgical Treatment of Objective Patellar Instability: Long-Term Results
por: Berruto, Massimo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fi1da16j168nmbnv6qs6o3ccvf